Grifols

ተከተል
Grifols executives in boardroom approving minority stake IPO for US Biopharma business, with surging stock charts on screens.
በ AI የተሰራ ምስል

Grifols prepares stock listing for its US Biopharma business

በAI የተዘገበ በ AI የተሰራ ምስል

Grifols' board has approved preparing a public offering (OPV) of a minority stake in its US Biopharma business to reduce debt and fund growth. The company will retain majority control and continue listing in Spain. Its ADRs surged up to 13% in after-hours trading.

ይህ ድረ-ገጽ ኩኪዎችን ይጠቀማል

የእኛን ጣቢያ ለማሻሻል ለትንታኔ ኩኪዎችን እንጠቀማለን። የእኛን የሚስጥር ፖሊሲ አንብቡ የሚስጥር ፖሊሲ ለተጨማሪ መረጃ።
ውድቅ አድርግ